Loading…
LENZ Therapeutics, Inc. is projected to decline to $5.47 by 2027, a -2% move from its current price of $5.59. LENZ is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $5.42 | $5.59 | $5.77 | +0.05% |
| Jul 14 | $5.35 | $5.60 | $5.85 | +0.09% |
| Jul 15 | $5.30 | $5.60 | $5.91 | +0.14% |
| Jul 16 | $5.26 | $5.60 | $5.97 | +0.19% |
| Jul 17 | $5.22 | $5.60 | $6.01 | +0.23% |
| Jul 18 | $5.19 | $5.61 | $6.06 | +0.28% |
| Jul 19 | $5.16 | $5.61 | $6.10 | +0.32% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.16 | $5.61 | $6.10 | +0.32% |
| Week 2 | $5.00 | $5.63 | $6.33 | +0.65% |
| Week 3 | $4.88 | $5.64 | $6.53 | +0.98% |
| Week 4 | $4.79 | $5.66 | $6.70 | +1.30% |
| Week 5 | $4.71 | $5.68 | $6.85 | +1.63% |
| Week 6 | $4.64 | $5.70 | $7.00 | +1.96% |
| Week 7 | $4.58 | $5.72 | $7.14 | +2.29% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults.
The company was founded in 2013 and is headquartered in Solana Beach, California. It was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc.
in June 2021. The asset is categorized under Healthcare.
LENZ Therapeutics, Inc. (LENZ) trades at $5.82 and has a market cap of $182.48M, ranking 3648. The current price sits amid a near-term trading setup with a longer-run forecast showing upside potential into the late decade and beyond.
A major floor 30.5% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.4% away) — a key level to hold.
The nearest ceiling, 42.9% above — a clean break opens room to run.
A major ceiling 135.2% above — clearing it would confirm fresh momentum.
Key LENZ support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LENZ market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.80 | Sell | $5.77 | Sell |
| MA 10 | $5.80 | Sell | $5.83 | Sell |
| MA 20 | $5.98 | Sell | $6.08 | Sell |
| MA 50 | $7.16 | Sell | $7.21 | Sell |
| MA 100 | $9.00 | Sell | $9.90 | Sell |
| MA 200 | $17.59 | Sell | $14.96 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 37.00 | Neutral |
| Stoch RSI (14) | 59.75 | Neutral |
| CCI (20) | -80.22 | Neutral |
| Williams %R (14) | -87.10 | Info |
| MACD (12,26,9) | 0.08 | Buy |
| ROC (12) | -2.78 | Sell |
| Bollinger %B (20,2) | 0.24 | Neutral |
| Stochastic %K (14) | 12.90 | Buy |
| TRIX (15) | -1.03 | Sell |
| Awesome (5,34) | -0.72 | Sell |
| Ultimate (7,14,28) | 42.43 | Neutral |
| Momentum (10) | 0.08 | Buy |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 5.87 | Sell |
| ADX (14) | 28.95 | Sell |
| ATR (14) | 0.21 | Info |
The 30-day technical picture is Neutral, with RSI14 at 30. The 30-day picture shows SMA50 at $8.17 and SMA200 at $19.89. The 30-day range spans from $4.70 to $7.21, with a defined support at $5.82 and resistance at $10.06.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.51 | $5.59 | $7.07 | 0% | Neutral | |
| $4.29 | $5.47 | $7.42 | -2% | Neutral | |
| $4.45 | $5.87 | $8.30 | +5% | Neutral | |
| $5.47 | $7.41 | $10.82 | +32% | Bullish | |
| $5.30 | $7.35 | $11.04 | +32% | Bullish | |
| $4.88 | $6.93 | $10.65 | +24% | Bullish | |
| $4.99 | $7.23 | $11.36 | +29% | Bullish | |
| $4.80 | $7.08 | $11.34 | +27% | Bullish | |
| $5.07 | $7.62 | $12.42 | +36% | Bullish | |
| $5.83 | $8.94 | $14.80 | +60% | Bullish | |
| $6.03 | $10.02 | $17.77 | +79% | Bullish | |
| $10.53 | $20.21 | $39.57 | +262% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $5.51 | $5.59 | $6.60 | +0.00% |
| August 2026 | $4.71 | $5.59 | $6.82 | -0.03% |
| September 2026 | $4.88 | $5.83 | $7.21 | +4.34% |
| October 2026 | $4.80 | $5.78 | $7.22 | -0.92% |
| November 2026 | $4.59 | $5.55 | $7.00 | -3.88% |
| December 2026 | $4.57 | $5.56 | $7.07 | +0.13% |
Click any year to see its month-by-month LENZ forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
LENZ Therapeutics, Inc.'s 2026 outlook centres on $5.59, within a $5.51 to $7.07 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, LENZ could reach as high as $7.42, with a base case around $5.47 and support toward $4.29 — roughly -2% from $5.59. A consolidation phase looks the most probable path here.
Expect LENZ to range from $4.45 to $8.30 through 2028. The $5.87 average target implies a +5% move from current prices. That is up +7% on the projected 2027 average. Price action looks broadly range-bound.
The LENZ price prediction for 2029 points to an average of $7.41 (low $5.47, high $10.82) — a potential gain of +32% on today's $5.59. Buyers look set to stay in control over this stretch.
In 2030, LENZ is projected to trade between $5.30 and $11.04, averaging $7.35 — a potential gain of +32% from today's $5.59. That is -1% versus the projected 2029 average. Momentum favours further upside here.
LENZ Therapeutics, Inc.'s 2031 outlook centres on $6.93, within a $4.88 to $10.65 range. That is -6% versus the projected 2030 average. That marks a +24% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, LENZ could reach as high as $11.36, with a base case around $7.23 and support toward $4.99 — roughly +29% from $5.59. Momentum favours further upside here.
Expect LENZ to range from $4.80 to $11.34 through 2033. The $7.08 average target implies a +27% move from current prices. That is -2% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
The LENZ price prediction for 2034 points to an average of $7.62 (low $5.07, high $12.42) — a potential gain of +36% on today's $5.59. Momentum favours further upside here.
In 2035, LENZ is projected to trade between $5.83 and $14.80, averaging $8.94 — a potential gain of +60% from today's $5.59. That is up +17% on the projected 2034 average. Buyers look set to stay in control over this stretch.
LENZ Therapeutics, Inc.'s 2040 outlook centres on $10.02, within a $6.03 to $17.77 range. That is up +12% on the projected 2035 average. That marks a +79% change versus current levels. Momentum favours further upside here.
By 2050, LENZ could reach as high as $39.57, with a base case around $20.21 and support toward $10.53 — roughly +262% from $5.59. Buyers look set to stay in control over this stretch.
Investing $1,000 in LENZ today (≈ 178.890877 LENZ) could be worth
$3,615.21
+$2,615.21 (+262%) by 2050 · US Dollar
Based on the average projected LENZ price of $20.21 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LENZwould be worth at today's price.
$1,000 invested in LENZ on Jul 10, 2025 (≈ 29.18856 LENZ) would be worth
$163.16
-$836.84 (-83.7%) today · 0.16× · US Dollar
Based on a LENZ entry price of $34.26 vs. today's $5.59.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.89 | $949.07 | -5.1% |
| 1 month ago | $6.58 | $849.54 | -15.0% |
| 3 months ago | $9.07 | $616.32 | -38.4% |
| 6 months ago | $15.57 | $359.02 | -64.1% |
| 1 year ago | $34.26 | $163.16 | -83.7% |
| All time (5.0y) ago | $180.18 | $31.02 | -96.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LENZ forecast.
Our base-case forecast reaches $11.00 around 2050.
Implied market cap at $11.00: $344.9M
In the multi-year forecast, LENZ shows a path of upside from late decade into the 2030s and beyond. The 2026 forecast is min $5.82, avg $5.82, max $7.47 with ROI 0 and Neutral sentiment. The 2027 forecast is min $4.42, avg $5.67, max $7.73 with ROI -2.6 and Neutral sentiment.
The 2028 forecast is min $4.75, avg $6.30, max $8.97 with ROI 8.2 and Neutral sentiment. The 2029 forecast is min $5.88, avg $8.01, max $11.78 with ROI 37.6 and Bullish sentiment. The 2030 forecast is min $5.46, avg $7.63, max $11.55 with ROI 31.1 and Bullish sentiment.
The 2031 forecast is min $5.09, avg $7.28, max $11.29 with ROI 25.2 and Bullish sentiment. The 2032 forecast is min $5.40, avg $7.88, max $12.49 with ROI 35.5 and Bullish sentiment. The 2033 forecast is min $4.95, avg $7.38, max $11.92 with ROI 26.8 and Bullish sentiment.
The 2034 forecast is min $5.35, avg $8.13, max $13.36 with ROI 39.6 and Bullish sentiment. The 2035 forecast is min $6.38, avg $9.88, max $16.51 with ROI 69.7 and Bullish sentiment. The 2040 forecast is min $6.52, avg $10.99, max $19.70 with ROI 88.9 and Bullish sentiment.
The 2050 forecast is min $11.14, avg $21.83, max $43.24 with ROI 275 and Bullish sentiment.
Tap a question to reveal the answer.
Avg $7.63; min $5.46; max $11.55; ROI 31.1; sentiment BULLISH.
Forecast shows bullish sentiment from 2029 onward with rising averages and notable upside; 2027 shows ROI -2.6, 2029 37.6, 2030 31.1, 2040 88.9, 2050 275. These are estimates, not guarantees.
Yes—the 2050 max is $43.24.
RSI14 is 30; SMA50 is $8.17; SMA200 is $19.89; 30-day range is $4.70 to $7.21; support is $5.82; resistance is $10.06; sentiment is NEUTRAL.
Current price is $5.82; market cap is $182.48M; rank is 3648.
LENZ Therapeutics, Inc. Community Discussion
0Share your LENZ Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.